Hemangioma of infancy is widely known as a glycolytic tumor indicated by (a) [F-18] fluoro-deoxyglucose uptake detected in positron emission tomography and (b) GLUT-1 expression, which promotes glucose uptake and glycolysis. This evidence concerns the gene SLC2A1 and neoplasm.